DUAKLIR PRESSAIR
Peakaclidinium bromide and formoterol fumarate
NDAINHALATIONPOWDER, METERED
Approved
Mar 2019
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
2
Mechanism of Action
bronchodilators: aclidinium a long-acting muscarinic antagonist (also known as an anticholinergic) and formoterol a long-acting beta 2 -adrenergic agonist. Further information regarding these two substances is provided below. The mechanism of action described below for the individual components…
Indications (3)
Clinical Trials (2)
Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Started Sep 2011
1,692 enrolled
Chronic Obstructive Pulmonary Disease
Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Started Jun 2008
156 enrolled
Pulmonary Disease, Chronic Obstructive
Loss of Exclusivity
LOE Date
Mar 13, 2029
36 months away
Patent Expiry
Mar 13, 2029